Learn More
Medchemexpress LLC Thalidomide-4-O-CH2-COO(t-Bu) | 1950635-36-5 | 99.26% | 388.37 | 100 MG

Supplier: Medchemexpress LLC HY42771100MG
Thalidomide-4-O-CH2-COO(t-Bu) is a t-Bu modified Thalidomide, which is the final step intermediate in the synthesis of Thalidomide-4-OH. It acts as a Cereblon ligand to recruit CRBN proteins. The t-Bu protecting group can be removed under acidic conditions to participate in the synthesis of PROTAC molecules. It is a key intermediate in the synthesis of CRBN-based designed PROTAC molecules.
- Acts as a Cereblon ligand to recruit CRBN proteins.
- The t-Bu protecting group can be removed under acidic conditions to participate in the synthesis of PROTAC molecules.
- Key intermediate in the synthesis of CRBN-based designed PROTAC molecules.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.